Related Experiment Video
Updated: Feb 6, 2026
07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
16.3K
Korea HIV/AIDS Cohort Study: study design and baseline characteristics
Bo Youl Choi1, Jun Yong Choi2, Sang Hoon Han2
1Department of Preventive Medicine, Hanyang university College of Medicine, Seoul, Korea.
Epidemiology and Health
|August 24, 2018
Summary
The Korea HIV/AIDS Cohort Study tracked 1,438 patients for a decade to improve HIV/AIDS prevention and treatment. Data from this long-term research will inform health policies and patient management strategies.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- HIV/AIDS cases in Korea have steadily risen since 1985, with over 15,000 infections by 2016.
- Approximately 1,100 new HIV/AIDS cases emerge annually in Korea.
- The Korea HIV/AIDS Cohort Study was initiated in 2006 to support evidence-based HIV/AIDS management.
Purpose of the Study:
- Establish a robust administrative system for HIV/AIDS cohort studies.
- Standardize research methodologies and case report forms.
- Develop data standardization and cleaning methods for multi-cohort analysis.
Main Methods:
- Longitudinal monitoring of 1,438 HIV/AIDS patients over 10 years (approx. 10% of Korea's total).
- Data collection aimed at monitoring at least 1,000 patients annually.
- Analysis of demographic data, including sex distribution (93.3% male) and ethnicity (98.9% Korean).
Main Results:
- Over 50% of participants were diagnosed with HIV after 2006.
- The study established standardized protocols for HIV/AIDS cohort research.
- Collected data provides a decade-long overview of the HIV/AIDS epidemic in Korea.
Conclusions:
- The study provides valuable long-term data for developing HIV/AIDS prevention and treatment policies.
- Findings will contribute to creating indices for optimizing HIV patient care and health promotion.
- The research supports evidence-based strategies for managing chronic infectious diseases like HIV/AIDS.
Related Concept Videos
01:15Study Design in Statistics
10.1K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.1K
01:20Study Designs in Epidemiology
1.0K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.0K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
246
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
246
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
362
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
362
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
160
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
160
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
250
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
250